ICDcodes.org
FY2027

E72.53Primary hyperoxaluria

Not billable

Is E72.53 billable?

No — E72.53 is a non-billable header code. E72.53 groups more specific codes and cannot be submitted on a claim. A valid ICD-10-CM code must be reported at the highest level of specificity available in its branch. Select one of the 3 billable codes beneath E72.53.

E72.53 at a glance

CodeE72.53
DescriptionPrimary hyperoxaluria
BillableNo — header code
Code setICD-10-CM FY2027
Valid for encountersOctober 1, 2026 – September 30, 2027

How is E72.53 listed in the Alphabetic Index?

These are the routes through the Alphabetic Index that lead to E72.53. They show the wording a clinician may have documented, which often differs from the Tabular description.

  • Oxalosis
  • Oxaluria
  • Hyperoxaluriaprimary
  • Disorderglycine metabolismoxalosis (of)
  • Disorderglycine metabolismoxaluria (of)
  • Disordermetabolism NOSamino-acidglycinehyperoxaluriaprimary (of)

Excludes1 — never code together

The conditions below can never be reported together with E72.53 on the same claim. An Excludes1 note means the two conditions cannot occur in the same patient, so reporting both is a coding error.

Inclusion terms

Alternative wording in documentation that is classified to E72.53.

  • Oxalosis
  • Oxaluria

Excludes1 — never code together — inherited from Chapter 4

The conditions below can never be reported together with E72.53 on the same claim. An Excludes1 note means the two conditions cannot occur in the same patient, so reporting both is a coding error.

  • transitory endocrine and metabolic disorders specific to newborn (P70-P74)

Excludes1 — never code together — inherited from E70-E88

The conditions below can never be reported together with E72.53 on the same claim. An Excludes1 note means the two conditions cannot occur in the same patient, so reporting both is a coding error.

  • androgen insensitivity syndrome (E34.5-)
  • congenital adrenal hyperplasia (E25.0)
  • hemolytic anemias attributable to enzyme disorders (D55.-)
  • Marfan syndrome (Q87.4-)
  • 5-alpha-reductase deficiency (E29.1)

Excludes1 — never code together — inherited from E72

The conditions below can never be reported together with E72.53 on the same claim. An Excludes1 note means the two conditions cannot occur in the same patient, so reporting both is a coding error.

  • disorders of:
  • aromatic amino-acid metabolism (E70.-)
  • branched-chain amino-acid metabolism (E71.0-E71.2)
  • fatty-acid metabolism (E71.3)
  • purine and pyrimidine metabolism (E79.-)
  • gout (M1A.-, M10.-)

Excludes2 — not included here — inherited from E70-E88

The conditions below are not part of E72.53, but a patient may have both at the same time. When documentation supports it, E72.53 and the excluded code may both be reported.

  • Ehlers-Danlos syndromes (Q79.6-)

What codes fall under E72.53? (3)

How long has E72.53 existed?

E72.53 has been in ICD-10-CM since at least FY2016, the earliest fiscal year on record here.

  • FY2026: E72.53 stopped being billable
Description changes
  • FY2019
    Hyperoxaluria
    Primary hyperoxaluria

Derived from the official order files for FY2016–FY2026. FY2017 and FY2020 publish no order file, so those years are not covered.

Which conditions are coded to E72.53?

What other codes are in the E72.5 family? (5)